PTGX logo

Protagonist Therapeutics (PTGX) Current Liabilities

PTGX Annual Current Liabilities

$21.27 M
-$9.90 M-31.77%

31 December 2023

PTGX Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PTGX Quarterly Current Liabilities

$44.58 M
+$3.00 M+7.22%

30 September 2024

PTGX Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PTGX Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-31.8%+7.2%
3 y3 years-47.1%+7.2%
5 y5 years-18.7%+7.2%

PTGX Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-51.7%at lowat high+109.5%
5 y5-year-51.7%at lowat high+109.5%
alltimeall time-51.7%+1475.8%-14.7%+1326.0%

Protagonist Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$44.58 M(+7.2%)
June 2024
-
$41.58 M(+4.2%)
Mar 2024
-
$39.91 M(+87.6%)
Dec 2023
$21.27 M(-31.8%)
$21.27 M(-23.7%)
Sept 2023
-
$27.87 M(+5.6%)
June 2023
-
$26.40 M(+13.6%)
Mar 2023
-
$23.23 M(-25.5%)
Dec 2022
$31.18 M(-29.2%)
$31.18 M(-15.2%)
Sept 2022
-
$36.75 M(-8.3%)
June 2022
-
$40.09 M(-7.8%)
Mar 2022
-
$43.46 M(-1.3%)
Dec 2021
$44.02 M(+9.4%)
$44.02 M(+12.4%)
Sept 2021
-
$39.16 M(-8.9%)
June 2021
-
$42.97 M(+24.5%)
Mar 2021
-
$34.52 M(-14.2%)
Dec 2020
$40.24 M
$40.24 M(+4.4%)
Sept 2020
-
$38.56 M(+9.1%)
June 2020
-
$35.36 M(-2.8%)
DateAnnualQuarterly
Mar 2020
-
$36.37 M(+2.7%)
Dec 2019
$35.41 M(+35.4%)
$35.41 M(+15.0%)
Sept 2019
-
$30.78 M(-7.6%)
June 2019
-
$33.32 M(+36.0%)
Mar 2019
-
$24.50 M(-6.3%)
Dec 2018
$26.16 M(-38.5%)
$26.16 M(+8.5%)
Sept 2018
-
$24.10 M(-16.9%)
June 2018
-
$29.02 M(-14.5%)
Mar 2018
-
$33.92 M(-20.3%)
Dec 2017
$42.55 M(+561.3%)
$42.55 M(-18.6%)
Sept 2017
-
$52.25 M(+457.8%)
June 2017
-
$9.37 M(+20.4%)
Mar 2017
-
$7.78 M(+20.9%)
Dec 2016
$6.43 M(+105.9%)
$6.43 M(+20.3%)
Sept 2016
-
$5.35 M(+30.1%)
June 2016
-
$4.11 M(-8.1%)
Mar 2016
-
$4.47 M(+43.0%)
Dec 2015
$3.13 M(+131.6%)
$3.13 M
Dec 2014
$1.35 M
-

FAQ

  • What is Protagonist Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Protagonist Therapeutics?
  • What is Protagonist Therapeutics annual current liabilities year-on-year change?
  • What is Protagonist Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Protagonist Therapeutics?
  • What is Protagonist Therapeutics quarterly current liabilities year-on-year change?

What is Protagonist Therapeutics annual total current liabilities?

The current annual current liabilities of PTGX is $21.27 M

What is the all time high annual current liabilities for Protagonist Therapeutics?

Protagonist Therapeutics all-time high annual total current liabilities is $44.02 M

What is Protagonist Therapeutics annual current liabilities year-on-year change?

Over the past year, PTGX annual total current liabilities has changed by -$9.90 M (-31.77%)

What is Protagonist Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of PTGX is $44.58 M

What is the all time high quarterly current liabilities for Protagonist Therapeutics?

Protagonist Therapeutics all-time high quarterly total current liabilities is $52.25 M

What is Protagonist Therapeutics quarterly current liabilities year-on-year change?

Over the past year, PTGX quarterly total current liabilities has changed by +$3.00 M (+7.22%)